 |
2 Products |  |
3 Diseases | | 2 Products |
|
2 Trials |  |
104 News |  |
| «12 |
- | timbetasin intravenous (RGN-352) / REGENXBIO
Trial suspension: A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction (clinicaltrials.gov) - Nov 15, 2012
P2, N=75, Suspended, Sponsor: RegeneRx Biopharmaceuticals, Inc.
Not yet recruiting --> Suspended
- | timbetasin intravenous (RGN-352) / REGENXBIO
Trial initiation date: A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction (clinicaltrials.gov) - Nov 15, 2012
P2, N=75, Suspended, Sponsor: RegeneRx Biopharmaceuticals, Inc.
Not yet recruiting --> Suspended Initiation date: Dec 2011 --> Mar 2013
- timbetasin topical (RGN-137) / RegeneRx
Trial termination: A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa (clinicaltrials.gov) - Jan 25, 2012
P2, N=30, Terminated, Sponsor: RegeneRx Biopharmaceuticals, Inc.
Initiation date: Dec 2011 --> Mar 2013 Completed --> Terminated; Lack of patient availability and expiration of study drug
- |||| timbetasin ophthalmic (RGN-259) / ReGenTree
Trial completion: Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye (clinicaltrials.gov) - Jan 3, 2012
P2, N=72, Completed, Sponsor: RegeneRx Biopharmaceuticals, Inc.
Completed --> Terminated; Lack of patient availability and expiration of study drug Active, not recruiting --> Completed